Testing effectiveness (Phase 2)Looking for participantsNCT07023731
What this trial is testing
Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation
Who this might be right for
KRAS G12D MutationAdvanced Solid Cancer
Arvinas Inc. 159